<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9825585</article-id>
    <article-id pub-id-type="pmid">36318264</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac968</article-id>
    <article-id pub-id-type="publisher-id">gkac968</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>SEdb 2.0: a comprehensive super-enhancer database of human and mouse</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Yuezhu</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Song</surname>
          <given-names>Chao</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhao</surname>
          <given-names>Jun</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Yuexin</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhao</surname>
          <given-names>Xilong</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Feng</surname>
          <given-names>Chenchen</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Guorui</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhu</surname>
          <given-names>Jiang</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Fan</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Qian</surname>
          <given-names>Fengcui</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Liwei</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Jian</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bai</surname>
          <given-names>Xuefeng</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ai</surname>
          <given-names>Bo</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Xinyu</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Qiuyu</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>Hunan Provincial Base for Scientific and Technological Innovation Cooperation, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China,</institution><addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Hengyang Medical School, University of South China,</institution><addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4700-5496</contrib-id>
        <name>
          <surname>Li</surname>
          <given-names>Chunquan</given-names>
        </name>
        <!--lcqbio@163.com-->
        <aff><institution>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, <addr-line>Daqing</addr-line> 163319, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>Hunan Provincial Base for Scientific and Technological Innovation Cooperation, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China,</institution><addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hengyang Medical School, University of South China</institution>, <addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <aff><institution>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Hengyang Medical School, University of South China,</institution><addr-line>Hengyang</addr-line>, <addr-line>Hunan</addr-line> 421001, <country country="CN">China</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +86 13272311691; Fax: +86 0734 8279018; Email: <email>lcqbio@163.com</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first four authors should be regarded as Joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>06</day>
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-11-01">
      <day>01</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>01</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <volume>51</volume>
    <issue>D1</issue>
    <fpage>D280</fpage>
    <lpage>D290</lpage>
    <history>
      <date date-type="accepted">
        <day>13</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>09</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>14</day>
        <month>9</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac968.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Super-enhancers (SEs) are cell-specific DNA cis-regulatory elements that can supervise the transcriptional regulation processes of downstream genes. SEdb 2.0 (<ext-link xlink:href="http://www.licpathway.net/sedb" ext-link-type="uri">http://www.licpathway.net/sedb</ext-link>) aims to provide a comprehensive SE resource and annotate their potential roles in gene transcriptions. Compared with SEdb 1.0, we have made the following improvements: (i) Newly added the mouse SEs and expanded the scale of human SEs. SEdb 2.0 contained 1 167 518 SEs from 1739 human H3K27ac chromatin immunoprecipitation sequencing (ChIP-seq) samples and 550 226 SEs from 931 mouse H3K27ac ChIP-seq samples, which was five times that of SEdb 1.0. (ii) Newly added transcription factor binding sites (TFBSs) in SEs identified by TF motifs and TF ChIP-seq data. (iii) Added comprehensive (epi)genetic annotations of SEs, including chromatin accessibility regions, methylation sites, chromatin interaction regions and topologically associating domains (TADs). (iv) Newly embedded and updated search and analysis tools, including ‘Search SE by TF-based’, ‘Differential-Overlapping-SE analysis’ and ‘SE-based TF–Gene analysis’. (v) Newly provided quality control (QC) metrics for ChIP-seq processing. In summary, SEdb 2.0 is a comprehensive update of SEdb 1.0, which curates more SEs and annotation information than SEdb 1.0. SEdb 2.0 provides a friendly platform for researchers to more comprehensively clarify the important role of SEs in the biological process.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>62171166</award-id>
        <award-id>62001145</award-id>
        <award-id>62272212</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Natural Science Foundation for Distinguished Young Scholars of Heilongjiang Province of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>JQ2020C004</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Research Foundation of the First Affiliated Hospital of University of South China for Advanced Talents</institution>
          </institution-wrap>
        </funding-source>
        <award-id>20210002-1005 USCAT-2021-01</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Wu Liande Youth Science Research Fund of Harbin Medical University (Daqing)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>JFWLD202001</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>China Postdoctoral Science Foundation</institution>
            <institution-id institution-id-type="DOI">10.13039/501100002858</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2019M661311</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Hunan Provincial Base for Scientific and Technological Innovation Cooperation</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2019CB1009</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="11"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Super-enhancers (SEs) are clusters composed of multiple enhancer constituents, which can program and regulate gene expression patterns. Similar to typical enhancers, SEs can recruit transcription factors (TFs), transcriptional co-factors, chromatin regulators and chromatin complexes to participate in transcriptional regulation processes (<xref rid="B1" ref-type="bibr">1</xref><xref rid="B2" ref-type="bibr">–</xref><xref rid="B3" ref-type="bibr">3</xref>). The difference is that the length of genome coverage and binding density of the active factors of SEs are several times or even dozens of times that of typical enhancers (<xref rid="B4" ref-type="bibr">4</xref>). The transcriptional regulation ability of SEs is much higher than that of typical enhancers (<xref rid="B5" ref-type="bibr">5</xref>). Importantly, a large number of studies have revealed that SEs can promote many biological processes, such as tumor occurrence and development, embryonic development, immune response, and cell invasion and metastasis, by regulating key genes in these processes. For example, SEs can promote the development of breast cancer by activating the key gene FOXC1 that enhances the regulation of cancer cell growth and metastasis (<xref rid="B6" ref-type="bibr">6</xref>). Moreover, studies have found that DNA methylation, sequence variation, and chromatin accessibility in the SE region could affect the regulatory potential of SEs (<xref rid="B7" ref-type="bibr">7</xref>). The dynamic changes of SE activity in different stages of development were related to the changes of chromatin state (<xref rid="B8" ref-type="bibr">8</xref>). DNA methylation affects the interaction between protein and DNA by causing changes in DNA conformation, which ultimately inhibits the binding efficiency of TFs and cis-regulatory elements such as SEs, enhancers and promoters (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>). In megakaryocytes, the common sequence variation in the cell type specific SE region changes platelet function (<xref rid="B11" ref-type="bibr">11</xref>). In conclusion, these studies have demonstrated that SEs had great regulatory potential in the development of complex diseases and the maintenance of healthy cell properties and functions.</p>
    <p>In the last few years, researchers have developed multiple SE related databases, such as dbSUPER (<xref rid="B12" ref-type="bibr">12</xref>) and SEA (<xref rid="B13" ref-type="bibr">13</xref>), which provide large amounts of SE information for researchers. For example, dbSUPER contains basic information such as the chromosomal location of the SE regions and related genes from human and mouse. SEA is mainly dedicated to curating multi-species SEs and a small amount of annotation information. We developed SEdb 1.0 in 2019 to annotate with multiple perspectives the functional effects of SEs on gene transcriptional regulation in a cell type-specific manner, which contained a multitude of human SEs and plentiful annotation data of SEs to decipher the transcriptional regulation mechanism (<xref rid="B14" ref-type="bibr">14</xref>). Moreover, after the SEdb 1.0 release, the continued rapid accumulation of multi-species ChIP-seq data provided valuable resources for exploring SE functions. In particular, the H3K27ac ChIP-seq data of mouse has accumulated in an unprecedented manner. Mouse models provide important research vehicles both for revealing the pathological molecular mechanisms and for the preclinical evaluation of therapies against a variety of human complex diseases, especially cardiovascular diseases and cancers. Emerging evidence has also demonstrated that mouse SEs play vital regulatory roles in cardiovascular diseases via activating downstream functional genes (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>). A large number of researchers have discovered that key TFs bind to SEs to supervise the transcriptional regulation capabilities of SEs for cell-specific genes, cancer driver genes and other important genes (<xref rid="B17" ref-type="bibr">17</xref>). The complex regulatory relationship between TFs and genes have been believed to be largely mediated by <italic toggle="yes">cis</italic> regulatory elements such as SEs, enhancers and promoters (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>). Meanwhile, numerous studies have shown that the chromatin features within SE regions, including DNA methylation, chromatin interaction and chromatin accessibility, are synergistic to control gene transcription (<xref rid="B20" ref-type="bibr">20</xref>). For instance, integrating ATAC-seq density and SE activity can construct core regulatory circuits and identify core causal TFs in cancers (<xref rid="B21" ref-type="bibr">21</xref>). Changes in three-dimensional (3D) chromatin architecture have a strong effect on the integrity of topologically associating domains (TADs) and rewiring specific enhancer–promoter interactions, which can lead to the dysregulated gene expression and cause diseases (<xref rid="B22" ref-type="bibr">22</xref>). Researchers revealed that the dynamic methylation of SEs regulated transcriptional heterogeneity (<xref rid="B23" ref-type="bibr">23</xref>). Therefore, further integrating these large-scale datasets to explore the functions of SEs and elucidate the transcriptional regulation mechanisms of SEs in different cell/tissue types is urgently required.</p>
    <p>We developed SEdb 2.0, an updated and significantly expanded database, which introduced the new SEs for mouse and included a major expansion of human SE resources, to provide a more comprehensive collection, interpretation and analysis of SEs. Currently, SEdb 2.0 documented 1 717 744 SEs from 2670 samples, including 541 original human samples, 1198 newly released human samples and 931 mouse samples. Notably, the scales of datasets and SEs have been increased by more than five times compared with SEdb 1.0. Importantly, SEdb 2.0 predicted TF binding within SE regions through TF motif analysis and TF ChIP-seq data. Briefly, we collected and processed TF binding data of &gt;1400 TFs from human and mouse to interpret the SE-related regulatory information across different cell/tissue types. Also, SEdb 2.0 newly extended genetic and epigenetic annotations from multiple perspectives, including chromatin accessibility regions, methylation sites, chromatin interactions regions, and TADs. Furthermore, SEdb 2.0 also added new analysis and search functions, such as ‘Search SE by TF-based’, ‘Differential-Overlapping-SE analysis’ and ‘SE-based TF–Gene analysis’ (Table <xref rid="tbl1" ref-type="table">1</xref>). Collectively, SEdb 2.0 is an easy-to-use platform to curate massive SE data of human and mouse, which provide comprehensive annotations and analysis tools for facilitating the interpretation of SEs (Figure <xref rid="F1" ref-type="fig">1</xref>).</p>
    <table-wrap position="float" id="tbl1">
      <label>Table 1.</label>
      <caption>
        <p>SEdb 2.0 data content compared with SEdb 1.0</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Function type</th>
            <th rowspan="1" colspan="1">Data type/specific function</th>
            <th rowspan="1" colspan="1">SEdb 1.0</th>
            <th rowspan="1" colspan="1">SEdb 2.0</th>
            <th rowspan="1" colspan="1">Fold increase</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Interaction table/annotation</td>
            <td rowspan="1" colspan="1">Species</td>
            <td rowspan="1" colspan="1">Human</td>
            <td rowspan="1" colspan="1">Human, Mouse</td>
            <td rowspan="1" colspan="1">2</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Sample</td>
            <td rowspan="1" colspan="1">542</td>
            <td rowspan="1" colspan="1">2670</td>
            <td rowspan="1" colspan="1">∼5</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Super-enhancer</td>
            <td rowspan="1" colspan="1">331 601</td>
            <td rowspan="1" colspan="1">1 717 744</td>
            <td rowspan="1" colspan="1">∼5</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Common SNP</td>
            <td rowspan="1" colspan="1">38 063 729</td>
            <td rowspan="1" colspan="1">79 078 255</td>
            <td rowspan="1" colspan="1">∼2</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">eQTL</td>
            <td rowspan="1" colspan="1">31 080 511</td>
            <td rowspan="1" colspan="1">61 786 727</td>
            <td rowspan="1" colspan="1">∼2</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Enhancer</td>
            <td rowspan="1" colspan="1">14 867 092</td>
            <td rowspan="1" colspan="1">79 709 120</td>
            <td rowspan="1" colspan="1">∼5</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Chromatin accessibility region</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Methylation site</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Chromatin interactions region</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TAD</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TF ChIP-seq</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TF motif scan analysis</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Genome browser</td>
            <td rowspan="1" colspan="1">Reference genome</td>
            <td rowspan="1" colspan="1">hg19</td>
            <td rowspan="1" colspan="1">hg38, hg19 mm10, mm39</td>
            <td rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Super-enhancer</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Super-enhancer element</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TFBS by ChIP-seq</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Methylation site</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TAD</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">SNP</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Common SNP</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Risk SNP</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">TFBS conserved</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">CRISPR/Cas9 target site</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">DHS</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Enhancer</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Conservative score</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Analysis functions</td>
            <td rowspan="1" colspan="1">Differential-Overlapping-SE analysis</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">SE-based TF–Gene analysis</td>
            <td rowspan="1" colspan="1">No</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Gene-SE analysis</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">SNP-SE analysis</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Overlap analysis</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Region analysis<sup>a</sup></td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="T1TFN1">
          <p><sup>a</sup>External link to GREAT.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>Database content and construction. SEdb2.0 uses multi-source H3K27ac ChIP-seq data to identify human and mouse super-enhancers. New genetic and epigenetic annotations are collected, such as accessible chromatin, methylation sites, chromatin interactions and so on. SEdb 2.0 contains a variety of functions to browse, search, download and visualize super-enhancers.</p>
      </caption>
      <graphic xlink:href="gkac968fig1" position="float"/>
    </fig>
  </sec>
  <sec id="SEC2">
    <title>DATA EXPANSION AND PRE-PROCESSING</title>
    <sec id="SEC2-1">
      <title>Data collection and identification of SEs</title>
      <p>The main improvements from SEdb 1.0 to SEdb 2.0 in this section are the addition of mouse SE sets, the extension of human SE scale, and optimized SE identification workflow. SEdb 2.0 included 1739 human H3K27ac ChIP-seq samples and 931 mouse H3K27ac ChIP-seq samples. We processed the newly collected data with updated workflow and reference genomes. Briefly, we firstly collected all H3K27ac ChIP-seq and corresponding input control sequencing data from NCBI GEO/SRA (<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref>), ENCODE (<xref rid="B26" ref-type="bibr">26</xref>), Roadmap (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B27" ref-type="bibr">27</xref>), Genomics of Gene Regulation Project (GGR) (<xref rid="B26" ref-type="bibr">26</xref>) and National Genomics Data Center Genome Sequence Archive (NGDC GSA) (<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B29" ref-type="bibr">29</xref>). It is worth mentioning that GSA is a new data source added in SEdb 2.0 and a new data repository for raw sequence reads in China. Second, for genome alignment, we replaced the previously used Bowtie (v0.12.9) (<xref rid="B30" ref-type="bibr">30</xref>) with Bowtie 2 (v2.4.4), which is more efficient and more suitable for ChIP-seq data. Meanwhile, the reference genome in alignment has also been upgraded (Human hg38 and Mouse mm10). Finally, for peak calling, we replaced MACS14 (<xref rid="B31" ref-type="bibr">31</xref>) with the optimized MACS2 (2.2.7) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). We identified 1,167,518 human SEs and 550 226 mouse SEs with the upgraded workflow. Furthermore, for the SEs contained in SEdb1.0, we converted all the SE regions into the hg38 genome using the liftOver (<ext-link xlink:href="http://genome.ucsc.edu/cgi-bin/hgLiftOver" ext-link-type="uri">http://genome.ucsc.edu/cgi-bin/hgLiftOver</ext-link>) tool of UCSC (<xref rid="B32" ref-type="bibr">32</xref>). In addition, since the ChIP-seq data come from different experiments using different antibodies, the quality of the ChIP-seq data becomes uneven. We used ChIPQC to calculate some quality assessment metrics, such as the SSD score, cross-coverage score at the fragment length, and percentage of reads within peaks, to generate a quality report for each ChIP-seq data. The generated quality report was displayed in the sample details page for user's reference.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Identification of TF binding sites on SEs</title>
      <p>TF binding is an important ability for SEs to participate in gene transcription. We used two strategies to further investigate the relationship between SEs and TFs in the transcriptional regulation process. One was TF ChIP-seq data based prediction, and the other was TF motif scan analysis. For TF ChIP-seq data based prediction, we collected 51 616 973 non-redundant binding regions from 817 human TFs and 32 985 444 non-redundant binding regions of 648 mouse TFs across various cell lines and tissue types from ReMap 2022 (<xref rid="B33" ref-type="bibr">33</xref>). Next, due to the special structure of SEs, we separated the SE element regions to more precisely find TF binding sites that bound to SEs. Finally, we used BEDTools (<xref rid="B34" ref-type="bibr">34</xref>) to perform the region overlap analysis for SE element regions and peaks from TF ChIP-seq data to identify potentially bound TFs. For TF motif scan analysis, we first collected the position weight matrices of TF motif from multiple sources, including Jolma2013 (<xref rid="B35" ref-type="bibr">35</xref>), JASPAR CORE 2020 vertebrates (<xref rid="B36" ref-type="bibr">36</xref>), Homeodomains (<xref rid="B37" ref-type="bibr">37</xref>), UniPROBE (<xref rid="B38" ref-type="bibr">38</xref>), and Wei2010 (<xref rid="B39" ref-type="bibr">39</xref>). Second, Find Individual Motif Occurrences (FIMO) (<xref rid="B40" ref-type="bibr">40</xref>), which is the part of the MEME (<xref rid="B41" ref-type="bibr">41</xref>) Suite software toolkit, was used to scan for the occurrences of motifs within every SE element region. Finally, we identified potential TFs binding to SEs with a <italic toggle="yes">P</italic>-value threshold of 1.0E–06.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Genetic and epigenetic annotations of SEs</title>
      <p>Genetic and epigenetic annotations within the SE regions affect the transcriptional regulatory ability of SE. We extended the annotation data of SEs in both quantity and type. Besides the abundant annotation information including common single-nucleotide polymorphisms (SNPs), motif changes, eQTLs, risk SNPs, TFBSs, CRISPR/Cas9 target sites, DNase I hypersensitive signals (DHSs) and enhancers provided by SEdb 1.0, SEdb 2.0 added more comprehensive genetic and epigenetic annotation information, including chromatin accessibility regions, methylation sites, chromatin interaction regions and TADs. Moreover, we also updated and extended the original annotation information in SEdb 1.0, such as common SNPs, eQTL-gene pairs and enhancers.</p>
      <sec id="SEC2-3-1">
        <title>Chromatin accessibility regions</title>
        <p>It was found that the complex relationships between the SEs and chromatin accessibility regions would help analyze the combination of TFs and the gene expression mechanism. Therefore, SEdb 2.0 added &gt;130 000 000 chromatin accessibility regions from ATACdb (<xref rid="B42" ref-type="bibr">42</xref>), which was the previous job of our research group. Briefly, we manually collected 2723 samples to cover multiple tissues or cell types from NCBI GEO/SRA (<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref>) and used Bowtie2 and MACS2 to identify chromatin accessibility regions.</p>
      </sec>
      <sec id="SEC2-3-2">
        <title>Chromatin interactions/TADs</title>
        <p>The complex three-dimensional chromatin landscapes formed by chromatin interaction are considered highly credible evidence for SEs to regulate downstream gene expression. We obtained 34 342 926 human chromatin interactions from Oncobase (<xref rid="B43" ref-type="bibr">43</xref>) and 4DGenome (<xref rid="B44" ref-type="bibr">44</xref>) and obtained 93 516 mouse chromatin interaction data from 4DGenome (<xref rid="B44" ref-type="bibr">44</xref>). TADs are also evidence of chromatin interaction, which can directly reveal the relationship between SEs and gene promoters (<xref rid="B45" ref-type="bibr">45</xref>,<xref rid="B46" ref-type="bibr">46</xref>). A total of 72 019 human TADs covering 21 tissues or cell lines were obtained from the 3D Genome Browser (<xref rid="B47" ref-type="bibr">47</xref>).</p>
      </sec>
      <sec id="SEC2-3-3">
        <title>Methylation</title>
        <p>DNA methylation status on gene cis-regulatory elements changes the binding density of TFs and further determines the transcriptional activity of genes. Therefore, annotating methylation sites in SE regions is extremely important. SEdb 2.0 collected a large amount of methylation data from two different technologies, which were 450K array and whole-genome shotgun bisulfite sequencing (WGBS). We downloaded 32 099 124 human methylation sites from 450k arrays and 176 535 822 human WGBS datasets from ENCODE (<xref rid="B26" ref-type="bibr">26</xref>).</p>
      </sec>
      <sec id="SEC2-3-4">
        <title>Common SNPs/eQTLs/SNPs</title>
        <p>SNPs in SE regions can affect the ability of SEs to regulate genes. Due to the upgrade of common SNP and eQTL related databases, we also re-collected the mutation data to provide up-to-date annotations. For example, the number of common SNPs (38063 729 to 79 078 255) obtained from dbSNP release 151 was about twice that of the previous ones (<xref rid="B48" ref-type="bibr">48</xref>). Also, eQTL-gene pairs were increased from 31 080 511 to 61 786 727. Besides, we collected 81,432,271 mouse SNPs from dbSNP release 151.</p>
      </sec>
      <sec id="SEC2-3-5">
        <title>Enhancers</title>
        <p>SEs are constituted by multiple active enhancers. We also expanded the source of enhancer to achieve a better understanding of the regulatory roles of SEs. The enhancer data sets from EnhancerAtlas (<xref rid="B49" ref-type="bibr">49</xref>), FANTOM5 (<xref rid="B50" ref-type="bibr">50</xref>), ENCODE (<xref rid="B26" ref-type="bibr">26</xref>), HANCER (<xref rid="B51" ref-type="bibr">51</xref>), DENdb (<xref rid="B52" ref-type="bibr">52</xref>) and ENdb (<xref rid="B53" ref-type="bibr">53</xref>) were collected and processed in this step, which contained 79,664,341 human enhancers and 44,779 mouse enhancers. Of these, a majority of enhancer sets were identified using high-throughput experimental data, such as FANTOM5 (<xref rid="B50" ref-type="bibr">50</xref>) and ENCODE (<xref rid="B26" ref-type="bibr">26</xref>). Notably, a subset of experimentally validated enhancers ENdb (<xref rid="B53" ref-type="bibr">53</xref>) were also collected, which were manually curated based on low-throughput experimental data.</p>
      </sec>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>DATABASE IMPROVED USER INTERFACE</title>
    <sec id="SEC3-1">
      <title>Search function of novel perspective</title>
      <p>SEdb 2.0 is a data platform with a more friendly search function. Four query methods exist that can inquire about SEs, including ‘Search SE by Tissue-Category-based’, ‘Search SE by gene-based’, ‘Search SE by genomic region’ and ‘Search SE by TF-based’. Among these, the TF-based query was newly added in SEdb 2.0 (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1B</xref>). The users can determine the scope of the SE query by selecting species and strategies and inputting TF names. In the result page, the users can retrieve the summary information of TF-based SE search results. TF overview, expression and disease details are also displayed. In the table of SE results, SEdb 2.0 provides the TF name, number of SEs bound by TFs in each sample, and detailed sample information, including sample ID, biosample type, tissue type, and biosample name. The users can click ‘detail’ to view the detailed information of TF associated SEs in the current sample, such as the SE region and SE ID. We also optimized the result pages of the previous three query results. For example, we added SE annotation visualization and the wordcloud of SE associated gene/TFs on the detail page of the SE sample. Meanwhile, we also added an SE associated network and candidate TF binding regions within SE regions predicted by motif analysis and TF ChIP-seq data on the detail page of the SE (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1A</xref>).</p>
    </sec>
    <sec id="SEC3-2">
      <title>New ‘Analysis’ interface for Differential-Overlapping-SE analysis tool</title>
      <p>SEdb1.0 provided three useful analysis tools to help investigate the SE functions in multiple perspectives, including ‘Gene-SE analysis’, ‘SNP-SE analysis’ and ‘Overlap analysis’. Importantly, SEs are considered as cell-specific DNA regulatory elements. We thus added a fourth analysis function named as ‘Differential-Overlapping-SE analysis’ to explore the differences between SEs from different cell types and disease states. In the ‘Differential-Overlapping-SE analysis’ function, the users can select two samples of interest from the same species based on the hierarchy between tissue types and samples. Simultaneously, SEdb 2.0 uses BEDTools (<xref rid="B34" ref-type="bibr">34</xref>) to compare reference genome locations to online analyze differential and overlapped SEs between the two submitted samples. In the result page, SEdb 2.0 can display detailed SE information, such as differential and overlapped SE regions, region length, overlapping ratio and SE associated genes. At the same time, two buttons (Gene Ontology (<xref rid="B54" ref-type="bibr">54</xref>) enrichment and KEGG (<xref rid="B55" ref-type="bibr">55</xref>) pathway enrichment) are provided for each sample to realize online enrichment analysis of specific SE associated genes using clusterProfiler (<xref rid="B56" ref-type="bibr">56</xref>) package in the current sample (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1C</xref>).</p>
    </sec>
    <sec id="SEC3-3">
      <title>New ‘Analysis’ interface for SE-based TF–Gene analysis tool</title>
      <p>Deciphering the complex relationship among TFs, SEs and genes in transcriptional regulatory mechanisms is the key to understanding the occurrence and development of diseases and biological processes. We provided the fifth analysis tool called SE-based TF–Gene analysis to better discover the relationship among them. When the users submit two lists of TF and gene and select species of interest, SEdb 2.0 identifies SE-mediated TF–gene pair(s) in different tissue types. Meanwhile, the users can set different statistical thresholds through the ‘FIMO’ option. On the analysis result page, SEdb 2.0 provides a drop-down box for selecting tissue type to view results from different tissue types. Numbers, genomic regions, and sample information of TF–gene pair(s) associated SEs can be displayed (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1D</xref>).</p>
    </sec>
    <sec id="SEC3-4">
      <title>Upgrade genome browser</title>
      <p>We also made a comprehensive upgrade of the original genome browser. Current genome browser contained multiple reference genomes per species, including human (hg38 and hg19) and mouse (mm10 and mm39). Respectively, hg38 and mm10 are displayed as default in human and mouse. At the same time, many new tracks such as TFBS by ChIP-seq data and TADs are embedded.</p>
    </sec>
    <sec id="SEC3-5">
      <title>Diverse data download</title>
      <p>SEdb 2.0 upgraded the reference genomes and provided multiple reference genomes, including hg19, hg38, mm10 and mm39 of SEs, typical enhancers and SE elements of all samples for download on the ‘Download’ page. It is worth noting that SEdb 2.0 also provided the package download of SEs, SE associated genes/TFs, SE elements, TEs based on different tissue/cell types. Moreover, the genetic and epigenetic annotations are also provided for download, such as common SNPs, risk SNPs, eQTLs, TADs, and DHSs. In addition, all the results obtained in the SE details page, search results page, and analysis results page can be downloaded through the ‘Download’ button.</p>
    </sec>
    <sec id="SEC3-6">
      <title>Case study</title>
      <sec id="SEC3-6-1">
        <title>Case study of SE-based TF–Gene analysis</title>
        <p>We performed ‘SE-based TF–Gene analysis’ by inputting mouse cardiac enriched TFs (Nkx2-5, Gata4, Mef2c and Mef2d) as TF input and mouse cardiac marker genes (Myh7, Myh6, Tnni3, Tnni1, Gata6, Acta1, Nkx2-5 and Mef2c) as gene input list to exhibit the new usage and potential applications of SEdb 2.0 in mouse model-based research fields, especially in cardiovascular diseases. We set the analysis parameters as species: mouse and FIMO: 1.0E–06 (Figure <xref rid="F2" ref-type="fig">2A</xref>). The analysis results showed a complex regulatory relationship between these TFs and the genes mediated by SEs (Figure <xref rid="F2" ref-type="fig">2B</xref>). The tissue distribution map of these SEs related to TF–gene pairs showed that most of them were distributed in heart-related tissues. For example, SEs enriched by Mef2d-Mef2c, Nkx2-5-Myh6, Myh7 and Gata4-Mef2c pairs were mainly distributed in the heart tissue. Intriguingly, Gata4-Nkx2-5, Myh6 and Myh7 pairs were distributed only in the heart or embryonic heart tissue (Figure <xref rid="F2" ref-type="fig">2C</xref>). This was consistent with previous findings of SEs in mediating TF–gene regulatory mechanisms, demonstrating that the Nkx2-5 upstream enhancer had a high-affinity binding site for the TF Gata4, thus activating and enhancing the transcription of Nkx2-5 in cardiac development (<xref rid="B57" ref-type="bibr">57</xref>,<xref rid="B58" ref-type="bibr">58</xref>). Meanwhile, normal Gata4 and Nkx2-5 activities might drive normal cardiac development and the mutation events on Gata4 and Nkx2-5 were considered as the causes of the occurrence and development of congenital heart disease (<xref rid="B59" ref-type="bibr">59</xref>,<xref rid="B60" ref-type="bibr">60</xref>). By clicking details, the users can further obtain the distribution of SEs that potentially mediate the current TF–gene pairs in various tissues and their general information. If the users want to view more detailed information about SEs, including SE overview, SE annotation and other genes and TFs associated with SEs, they can click SE ID, such as ‘SE_11_001000006’, ‘SE_11_001100180’ and so on. For SE ‘SE_11_001000006’ the detailed result showed that multiple GATA4-binding sites were identified in this SE region by overlapping cardiac related GATA4 TF ChIP-seq data, which further confirmed the regulatory relationship between GATA4, Nkx2-5 SEs (SE_11_001000006) and Nkx2-5 (Figure <xref rid="F2" ref-type="fig">2D</xref>). Most of the transcriptional regulatory axes composed of TFs and genes have been demonstrated to be regulated by SEs or enhancers. The dysregulation of these pairs can affect heart development and the occurrence and development of cardiovascular diseases. In general, SEdb 2.0 can help users further understand the regulatory relationship between TFs and genes mediated by SEs.</p>
        <fig position="float" id="F2">
          <label>Figure 2.</label>
          <caption>
            <p>Results of ‘SE-based TF–Gene analysis’ for mouse cardiac enriched TF list and marker gene list. (<bold>A</bold>) User submits gene list and TF list of interest. (<bold>B</bold>) Results overview for SE-based TF–Gene Analysis. (<bold>C</bold>) TF–gene pair associated super-enhancer details. (<bold>D</bold>) Detailed results for super-enhancer ‘SE_11_001000006’.</p>
          </caption>
          <graphic xlink:href="gkac968fig2" position="float"/>
        </fig>
      </sec>
      <sec id="SEC3-6-2">
        <title>Case study of Differential-Overlapping-SE analysis</title>
        <p>We selected two human samples, including pancreatic cancer cell line PSN1 (Biosample_name: PSN1-untreated, Sample ID: Sample_02_1372) and healthy pancreas tissues (Biosample_name: pancreas, Sample ID: Sample_00_0030) as input to highlight the usage of ‘Differential-Overlapping-SE analysis’ (Figure <xref rid="F3" ref-type="fig">3A</xref>). A total of 469 specific SEs in pancreatic cancer cell line PSN1 and 383 specific SEs in healthy pancreas tissues were identified in this analysis. As expected, many differential SE-associated genes in PSN1 were the key genes of pancreatic cancer, such as S100A4, S100A6, S100A2, NTSR1 and CDK5 (Figure <xref rid="F3" ref-type="fig">3B</xref>). Studies showed that S100 calcium binding protein A (S100A) family members were associated with the occurrence and development of pancreatic cancer (<xref rid="B61" ref-type="bibr">61</xref>). Among these, S100A4 promoted pancreatic cancer progression and accelerated cell motility by activating the Src-FAK-mediated dual signaling pathway in pancreatic cancer cells (<xref rid="B62" ref-type="bibr">62</xref>,<xref rid="B63" ref-type="bibr">63</xref>). Moreover, the inhibition of S100A6 expression reduced the proliferation and invasiveness of pancreatic cancer cells (<xref rid="B64" ref-type="bibr">64</xref>). Thus, S100 calcium-binding protein A family members are increasingly recognized as diagnostic markers and therapeutic targets for pancreatic cancer (<xref rid="B65" ref-type="bibr">65–68</xref>). Meanwhile, NTSR1 is also considered to be closely related to pancreatic cancer. The overexpression of NTSR1 induced high tumorigenic and metastatic capacity in pancreatic cancer cells (<xref rid="B69" ref-type="bibr">69</xref>). We obtained the pathway results annotated by differential SE-associated genes in the PSN1 cell line by clicking the KEGG pathway enrichment button of sample PSN1-untreated. The pathways significantly enriched by these specific SE associated genes in pancreatic cancer are microRNAs in cancer, mocal adhesion, insulin signaling pathway, PI3K-Akt signaling pathway, pancreatic cancer, regulation of actin cytoskeleton, MAPK signaling pathway and other cancer related pathways (Figure <xref rid="F3" ref-type="fig">3C</xref>). PI3K-Akt signaling pathway is abnormally activated in pancreatic cancer, affecting multiple biological processes such as cancer cell cycle progression and cellular metabolic rate, and associated with poor prognosis of patients (<xref rid="B69" ref-type="bibr">69–71</xref>). Indeed, Li <italic toggle="yes">et al.</italic> demonstrated that scoparone targeted the PI3K/Akt signaling pathway to induce cell cycle arrest and apoptosis in pancreatic cancer cells (<xref rid="B72" ref-type="bibr">72</xref>). However, the specific SE associated genes in healthy pancreas tissues are generally associated with pancreatic development, such as HNF1B, IPF1 and PBX1 (<xref rid="B73" ref-type="bibr">73</xref>) (Figure <xref rid="F3" ref-type="fig">3B</xref>). For example, HNF1B can control pancreatic pluripotent progenitor cell expansion, as well as pancreatic morphogenesis in mouse (<xref rid="B74" ref-type="bibr">74</xref>). HNF1B heterozygous mutations were associated with pancreatic hypoplasia in human (<xref rid="B75" ref-type="bibr">75</xref>). Furthermore, the Gene Ontology enrichment analysis of these specific SE associated genes in healthy pancreatic tissues showed that these SE associated genes were annotated in development related biological processes, such as cell growth, epithelial cell proliferation and migration. In conclusion, these analyses in our database could identify specific SE target genes associated with different phenotypes, showing that SEdb 2.0 is valuable in exploring the differences between different tissues, cell types, and phenotypes from the perspective of SEs.</p>
        <fig position="float" id="F3">
          <label>Figure 3.</label>
          <caption>
            <p>Results of ‘Differential-Overlapping-SE analysis’ between PSN1 and healthy pancreas tissues. (<bold>A</bold>) User selects two samples of interest. (<bold>B</bold>) Wordcloud map of specific super-enhancer associated genes in samples. (<bold>C</bold>) Differential super-enhancers and overlapping super-enhancers.</p>
          </caption>
          <graphic xlink:href="gkac968fig3" position="float"/>
        </fig>
        <p>In addition, we also performed ‘Search super-enhancers by TF-based’ to search mouse TF Nanog. The results showed that the SEs bound by TF Nanog were enriched in mouse embryonic stem cell samples, and these SEs and their related genes constituted the specific core pluripotent regulatory network to embryonic stem cells (<xref rid="sup1" ref-type="supplementary-material">Supplementary Materials</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2</xref>). These findings suggested that SEdb 2.0 was useful in finding SEs of interest by searching TF.</p>
      </sec>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC4">
    <title>CONCLUSIONS AND FUTURE EXTENSIONS</title>
    <p>In recent years, the key role of SEs in cell identity, disease development, and biological processes has been found and well investigated via low-throughput experiments (<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B76" ref-type="bibr">76</xref>). We developed the update of SEdb 2.0 by processing a large number of H3K27ac ChIP-seq data from new tissues and cell types to expand the human SE scale and introduce the SEs of mouse to provide more regulatory cues for human and mouse SEs. We also identified TF binding sites within SE regions via two strategies: TF motif scan analysis and TF ChIP-seq data. At the same time, SEdb 2.0 extended more comprehensive genetic and epigenetic annotations within SE regions and provided more useful query and analysis functions to interpret SE mediated transcriptional regulation. Among these, the GREAT (<xref rid="B77" ref-type="bibr">77</xref>) based genomic region annotation function of search results connects the position of SE on the genome with its biological function. Differential-Overlapping-SE analysis tool can help researchers find disease specific SE regions and provide potential targets for disease treatment and prognosis. Also, SE-based TF–Gene analysis tool interprets the complex interaction between TFs and genes from the perspective of SEs. The newly added genetic and epigenetic annotations of SEs, such as chromatin accessible regions, DNA methylation and so on, provide a multi-dimensional and in-depth perspective to understand the regulatory mechanism of SEs. In general, the updated SEdb enables the users to better understand the key role of SEs in the occurrence of complex diseases, embryonic development, immune response and other biological processes.</p>
    <p>In the future, we will continue to update and maintain SEdb. SEdb will be improved in the following three directions. First, SEdb will collect more H3K27ac ChIP-seq data from different tissue/cell types and disease phenotypes and further increase SE-related annotation information. Second, as the relationship between SEs and diseases is gradually revealed, SE-targeted therapy has become the novel clinical treatment options, especially in multiple cancers. We will follow up the investigations between drugs and SEs and integrate these data in the future version of SEdb. Finally, single-cell sequencing technology, such as scATAC-seq and scCUT&amp;Tag (<xref rid="B78" ref-type="bibr">78</xref>), continues to develop and enabling the identification of cell-specific SEs at single cell resolution. We will continue to track the development of this field to achieve large-scale single-cell level SEs recognition and curation. We believe that SEdb will facilitate SE research with more researchers.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p>The research community can access information freely in the SEdb 2.0 without registration or logging in. The URL for SEdb 2.0 is <ext-link xlink:href="http://www.licpathway.net/sedb/" ext-link-type="uri">http://www.licpathway.net/sedb/</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkac968_Supplemental_Files</label>
      <media xlink:href="gkac968_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec id="SEC6">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkac968#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>This work was supported by National Natural Science Foundation of China [62171166, 62001145, 62272212]; Natural Science Foundation for Distinguished Young Scholars of Heilongjiang Province of China [JQ2020C004]; Research Foundation of the First Affiliated Hospital of University of South China for Advanced Talents [20210002-1005 USCAT-2021-01]; Wu Liande Youth Science Research Fund of Harbin Medical University (Daqing) [JFWLD202001]; China Postdoctoral Science Foundation [2019M661311]; Hunan Provincial Base for Scientific and Technological Innovation Cooperation [2019CB1009].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hnisz</surname><given-names>D.</given-names></string-name>, <string-name><surname>Abraham</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>T.I.</given-names></string-name>, <string-name><surname>Lau</surname><given-names>A.</given-names></string-name>, <string-name><surname>Saint-Andre</surname><given-names>V.</given-names></string-name>, <string-name><surname>Sigova</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Hoke</surname><given-names>H.A.</given-names></string-name>, <string-name><surname>Young</surname><given-names>R.A.</given-names></string-name></person-group><article-title>Super-enhancers in the control of cell identity and disease</article-title>. <source>Cell</source>. <year>2013</year>; <volume>155</volume>:<fpage>934</fpage>–<lpage>947</lpage>.<pub-id pub-id-type="pmid">24119843</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feng</surname><given-names>C.</given-names></string-name>, <string-name><surname>Song</surname><given-names>C.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Qian</surname><given-names>F.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>KnockTF: a comprehensive human gene expression profile database with knockdown/knockout of transcription factors</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D93</fpage>–<lpage>D100</lpage>.<pub-id pub-id-type="pmid">31598675</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Song</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>L.</given-names></string-name>, <string-name><surname>Pan</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Shang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>TcoFBase:a comprehensive database for decoding the regulatory transcription co-factors in human and mouse</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D391</fpage>–<lpage>D401</lpage>.<pub-id pub-id-type="pmid">34718747</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jia</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>F.</given-names></string-name></person-group><article-title>Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms</article-title>. <source>Exp. Mol. Med.</source><year>2020</year>; <volume>52</volume>:<fpage>713</fpage>–<lpage>723</lpage>.<pub-id pub-id-type="pmid">32382065</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name></person-group><article-title>Super-enhancer function and its application in cancer targeted therapy</article-title>. <source>NPJ Precis. Oncol.</source><year>2020</year>; <volume>4</volume>:<fpage>2</fpage>.<pub-id pub-id-type="pmid">32128448</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Maryam</surname><given-names>A.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ramakrishnan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>V.W.S.</given-names></string-name>, <string-name><surname>Cheuk</surname><given-names>W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling</article-title>. <source>Nat. Commun.</source><year>2021</year>; <volume>12</volume>:<fpage>2242</fpage>.<pub-id pub-id-type="pmid">33854062</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fouse</surname><given-names>S.D.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pellegrini</surname><given-names>M.</given-names></string-name>, <string-name><surname>Cole</surname><given-names>S.</given-names></string-name>, <string-name><surname>Meissner</surname><given-names>A.</given-names></string-name>, <string-name><surname>Van Neste</surname><given-names>L.</given-names></string-name>, <string-name><surname>Jaenisch</surname><given-names>R.</given-names></string-name>, <string-name><surname>Fan</surname><given-names>G.</given-names></string-name></person-group><article-title>Promoter CpG methylation contributes to ES cell gene regulation in parallel with oct4/nanog, PcG complex, and histone H3 K4/K27 trimethylation</article-title>. <source>Cell Stem Cell</source>. <year>2008</year>; <volume>2</volume>:<fpage>160</fpage>–<lpage>169</lpage>.<pub-id pub-id-type="pmid">18371437</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Trevino</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Sinnott-Armstrong</surname><given-names>N.</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yoon</surname><given-names>S.J.</given-names></string-name>, <string-name><surname>Huber</surname><given-names>N.</given-names></string-name>, <string-name><surname>Pritchard</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Chang</surname><given-names>H.Y.</given-names></string-name>, <string-name><surname>Greenleaf</surname><given-names>W.J.</given-names></string-name>, <string-name><surname>Pasca</surname><given-names>S.P.</given-names></string-name></person-group><article-title>Chromatin accessibility dynamics in a model of human forebrain development</article-title>. <source>Science</source>. <year>2020</year>; <volume>367</volume>:<fpage>eaay1645</fpage>.<pub-id pub-id-type="pmid">31974223</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lhoumaud</surname><given-names>P.</given-names></string-name>, <string-name><surname>Sethia</surname><given-names>G.</given-names></string-name>, <string-name><surname>Izzo</surname><given-names>F.</given-names></string-name>, <string-name><surname>Sakellaropoulos</surname><given-names>T.</given-names></string-name>, <string-name><surname>Snetkova</surname><given-names>V.</given-names></string-name>, <string-name><surname>Vidal</surname><given-names>S.</given-names></string-name>, <string-name><surname>Badri</surname><given-names>S.</given-names></string-name>, <string-name><surname>Cornwell</surname><given-names>M.</given-names></string-name>, <string-name><surname>Di Giammartino</surname><given-names>D.C.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>K.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>EpiMethylTag: simultaneous detection of ATAC-seq or chip-seq signals with DNA methylation</article-title>. <source>Genome Biol.</source><year>2019</year>; <volume>20</volume>:<fpage>248</fpage>.<pub-id pub-id-type="pmid">31752933</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maurano</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>H.</given-names></string-name>, <string-name><surname>John</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shafer</surname><given-names>A.</given-names></string-name>, <string-name><surname>Canfield</surname><given-names>T.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>K.</given-names></string-name>, <string-name><surname>Stamatoyannopoulos</surname><given-names>J.A.</given-names></string-name></person-group><article-title>Role of DNA methylation in modulating transcription factor occupancy</article-title>. <source>Cell Rep.</source><year>2015</year>; <volume>12</volume>:<fpage>1184</fpage>–<lpage>1195</lpage>.<pub-id pub-id-type="pmid">26257180</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petersen</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lambourne</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Javierre</surname><given-names>B.M.</given-names></string-name>, <string-name><surname>Grassi</surname><given-names>L.</given-names></string-name>, <string-name><surname>Kreuzhuber</surname><given-names>R.</given-names></string-name>, <string-name><surname>Ruklisa</surname><given-names>D.</given-names></string-name>, <string-name><surname>Rosa</surname><given-names>I.M.</given-names></string-name>, <string-name><surname>Tome</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Elding</surname><given-names>H.</given-names></string-name>, <string-name><surname>van Geffen</surname><given-names>J.P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Platelet function is modified by common sequence variation in megakaryocyte super enhancers</article-title>. <source>Nat. Commun.</source><year>2017</year>; <volume>8</volume>:<fpage>16058</fpage>.<pub-id pub-id-type="pmid">28703137</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khan</surname><given-names>A.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X.</given-names></string-name></person-group><article-title>dbSUPER: a database of super-enhancers in mouse and human genome</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D164</fpage>–<lpage>D171</lpage>.<pub-id pub-id-type="pmid">26438538</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>X.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name></person-group><article-title>SEA version 3.0: a comprehensive extension and update of the super-enhancer archive</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D198</fpage>–<lpage>D203</lpage>.<pub-id pub-id-type="pmid">31667506</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Qian</surname><given-names>F.</given-names></string-name>, <string-name><surname>Bai</surname><given-names>X.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Ai</surname><given-names>B.</given-names></string-name>, <string-name><surname>Han</surname><given-names>X.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name><etal>et al</etal>.</person-group><article-title>SEdb: a comprehensive human super-enhancer database</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D235</fpage>–<lpage>D243</lpage>.<pub-id pub-id-type="pmid">30371817</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>H.</given-names></string-name>, <string-name><surname>Si</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>G.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liao</surname><given-names>W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Loss of super-enhancer-regulated circRNA nfix induces cardiac regeneration after myocardial infarction in adult mice</article-title>. <source>Circulation</source>. <year>2019</year>; <volume>139</volume>:<fpage>2857</fpage>–<lpage>2876</lpage>.<pub-id pub-id-type="pmid">30947518</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Micheletti</surname><given-names>R.</given-names></string-name>, <string-name><surname>Plaisance</surname><given-names>I.</given-names></string-name>, <string-name><surname>Abraham</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Sarre</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ting</surname><given-names>C.C.</given-names></string-name>, <string-name><surname>Alexanian</surname><given-names>M.</given-names></string-name>, <string-name><surname>Maric</surname><given-names>D.</given-names></string-name>, <string-name><surname>Maison</surname><given-names>D.</given-names></string-name>, <string-name><surname>Nemir</surname><given-names>M.</given-names></string-name>, <string-name><surname>Young</surname><given-names>R.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The long noncoding RNA wisper controls cardiac fibrosis and remodeling</article-title>. <source>Sci. Transl. Med.</source><year>2017</year>; <volume>9</volume>:<fpage>eaai9118</fpage>.<pub-id pub-id-type="pmid">28637928</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kalna</surname><given-names>V.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Peghaire</surname><given-names>C.R.</given-names></string-name>, <string-name><surname>Frudd</surname><given-names>K.</given-names></string-name>, <string-name><surname>Hannah</surname><given-names>R.</given-names></string-name>, <string-name><surname>Shah</surname><given-names>A.V.</given-names></string-name>, <string-name><surname>Osuna Almagro</surname><given-names>L.</given-names></string-name>, <string-name><surname>Boyle</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Gottgens</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ferrer</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The transcription factor ERG regulates super-enhancers associated with an endothelial-specific gene expression program</article-title>. <source>Circ. Res.</source><year>2019</year>; <volume>124</volume>:<fpage>1337</fpage>–<lpage>1349</lpage>.<pub-id pub-id-type="pmid">30892142</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van Groningen</surname><given-names>T.</given-names></string-name>, <string-name><surname>Koster</surname><given-names>J.</given-names></string-name>, <string-name><surname>Valentijn</surname><given-names>L.J.</given-names></string-name>, <string-name><surname>Zwijnenburg</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Akogul</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hasselt</surname><given-names>N.E.</given-names></string-name>, <string-name><surname>Broekmans</surname><given-names>M.</given-names></string-name>, <string-name><surname>Haneveld</surname><given-names>F.</given-names></string-name>, <string-name><surname>Nowakowska</surname><given-names>N.E.</given-names></string-name>, <string-name><surname>Bras</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Neuroblastoma is composed of two super-enhancer-associated differentiation states</article-title>. <source>Nat. Genet.</source><year>2017</year>; <volume>49</volume>:<fpage>1261</fpage>–<lpage>1266</lpage>.<pub-id pub-id-type="pmid">28650485</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>H.</given-names></string-name></person-group><article-title>iPro-WAEL: a comprehensive and robust framework for identifying promoters in multiple species</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>10278</fpage>–<lpage>10289</lpage>.<pub-id pub-id-type="pmid">36161334</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kou</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>R.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Gu</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Chromatin architecture reorganization in murine somatic cell nuclear transfer embryos</article-title>. <source>Nat. Commun.</source><year>2020</year>; <volume>11</volume>:<fpage>1813</fpage>.<pub-id pub-id-type="pmid">32286279</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ott</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Federation</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>L.S.</given-names></string-name>, <string-name><surname>Kasar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Klitgaard</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Lenci</surname><given-names>R.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Lawlor</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fernandes</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Souza</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia</article-title>. <source>Cancer Cell</source>. <year>2018</year>; <volume>34</volume>:<fpage>982</fpage>–<lpage>995</lpage>.<pub-id pub-id-type="pmid">30503705</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kloetgen</surname><given-names>A.</given-names></string-name>, <string-name><surname>Thandapani</surname><given-names>P.</given-names></string-name>, <string-name><surname>Ntziachristos</surname><given-names>P.</given-names></string-name>, <string-name><surname>Ghebrechristos</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Nomikou</surname><given-names>S.</given-names></string-name>, <string-name><surname>Lazaris</surname><given-names>C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Bakogianni</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Three-dimensional chromatin landscapes in t cell acute lymphoblastic leukemia</article-title>. <source>Nat. Genet.</source><year>2020</year>; <volume>52</volume>:<fpage>388</fpage>–<lpage>400</lpage>.<pub-id pub-id-type="pmid">32203470</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Song</surname><given-names>Y.</given-names></string-name>, <string-name><surname>van den Berg</surname><given-names>P.R.</given-names></string-name>, <string-name><surname>Markoulaki</surname><given-names>S.</given-names></string-name>, <string-name><surname>Soldner</surname><given-names>F.</given-names></string-name>, <string-name><surname>Dall’Agnese</surname><given-names>A.</given-names></string-name>, <string-name><surname>Henninger</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Drotar</surname><given-names>J.</given-names></string-name>, <string-name><surname>Rosenau</surname><given-names>N.</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Young</surname><given-names>R.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Dynamic enhancer DNA methylation as basis for transcriptional and cellular heterogeneity of ESCs</article-title>. <source>Mol. Cell</source>. <year>2019</year>; <volume>75</volume>:<fpage>905</fpage>–<lpage>920</lpage>.<pub-id pub-id-type="pmid">31422875</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barrett</surname><given-names>T.</given-names></string-name>, <string-name><surname>Troup</surname><given-names>D.B.</given-names></string-name>, <string-name><surname>Wilhite</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Ledoux</surname><given-names>P.</given-names></string-name>, <string-name><surname>Evangelista</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>I.F.</given-names></string-name>, <string-name><surname>Tomashevsky</surname><given-names>M.</given-names></string-name>, <string-name><surname>Marshall</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Phillippy</surname><given-names>K.H.</given-names></string-name>, <string-name><surname>Sherman</surname><given-names>P.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>NCBI GEO: archive for functional genomics data sets–10 years on</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>; <volume>39</volume>:<fpage>D1005</fpage>–<lpage>D1010</lpage>.<pub-id pub-id-type="pmid">21097893</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kodama</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Shumway</surname><given-names>M.</given-names></string-name>, <string-name><surname>Leinonen</surname><given-names>R.</given-names></string-name><collab>International Nucleotide Sequence Database, C.</collab></person-group><article-title>The sequence read archive: explosive growth of sequencing data</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>; <volume>40</volume>:<fpage>D54</fpage>–<lpage>D56</lpage>.<pub-id pub-id-type="pmid">22009675</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><collab>The ENCODE Project Consortium</collab><article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>. <source>Nature</source>. <year>2012</year>; <volume>489</volume>:<fpage>57</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">22955616</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bernstein</surname><given-names>B.E.</given-names></string-name>, <string-name><surname>Stamatoyannopoulos</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Costello</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>B.</given-names></string-name>, <string-name><surname>Milosavljevic</surname><given-names>A.</given-names></string-name>, <string-name><surname>Meissner</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kellis</surname><given-names>M.</given-names></string-name>, <string-name><surname>Marra</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Beaudet</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Ecker</surname><given-names>J.R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The NIH roadmap epigenomics mapping consortium</article-title>. <source>Nat. Biotechnol.</source><year>2010</year>; <volume>28</volume>:<fpage>1045</fpage>–<lpage>1048</lpage>.<pub-id pub-id-type="pmid">20944595</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><collab>CNCB-NGDC Members and Partners</collab><article-title>Database resources of the national genomics data center, china national center for bioinformation in 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D18</fpage>–<lpage>D28</lpage>.<pub-id pub-id-type="pmid">33175170</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Song</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>T.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Dong</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>N.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Q.</given-names></string-name><etal>et al</etal>.</person-group><article-title>GSA: genome sequence archive</article-title>. <source>Genomics Proteomics Bioinformatics</source>. <year>2017</year>; <volume>15</volume>:<fpage>14</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">28387199</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Langmead</surname><given-names>B.</given-names></string-name>, <string-name><surname>Salzberg</surname><given-names>S.L.</given-names></string-name></person-group><article-title>Fast gapped-read alignment with bowtie 2</article-title>. <source>Nat. Methods</source>. <year>2012</year>; <volume>9</volume>:<fpage>357</fpage>–<lpage>359</lpage>.<pub-id pub-id-type="pmid">22388286</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>T.</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Eeckhoute</surname><given-names>J.</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Bernstein</surname><given-names>B.E.</given-names></string-name>, <string-name><surname>Nusbaum</surname><given-names>C.</given-names></string-name>, <string-name><surname>Myers</surname><given-names>R.M.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>M.</given-names></string-name>, <string-name><surname>Li</surname><given-names>W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Model-based analysis of chip-Seq (MACS)</article-title>. <source>Genome Biol.</source><year>2008</year>; <volume>9</volume>:<fpage>R137</fpage>.<pub-id pub-id-type="pmid">18798982</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Navarro Gonzalez</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zweig</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Speir</surname><given-names>M.L.</given-names></string-name>, <string-name><surname>Schmelter</surname><given-names>D.</given-names></string-name>, <string-name><surname>Rosenbloom</surname><given-names>K.R.</given-names></string-name>, <string-name><surname>Raney</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Powell</surname><given-names>C.C.</given-names></string-name>, <string-name><surname>Nassar</surname><given-names>L.R.</given-names></string-name>, <string-name><surname>Maulding</surname><given-names>N.D.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>C.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The UCSC genome browser database: 2021 update</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D1046</fpage>–<lpage>D1057</lpage>.<pub-id pub-id-type="pmid">33221922</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hammal</surname><given-names>F.</given-names></string-name>, <string-name><surname>de Langen</surname><given-names>P.</given-names></string-name>, <string-name><surname>Bergon</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lopez</surname><given-names>F.</given-names></string-name>, <string-name><surname>Ballester</surname><given-names>B.</given-names></string-name></person-group><article-title>ReMap 2022: a database of human, mouse, drosophila and arabidopsis regulatory regions from an integrative analysis of DNA-binding sequencing experiments</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D316</fpage>–<lpage>D325</lpage>.<pub-id pub-id-type="pmid">34751401</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quinlan</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Hall</surname><given-names>I.M.</given-names></string-name></person-group><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinformatics</source>. <year>2010</year>; <volume>26</volume>:<fpage>841</fpage>–<lpage>842</lpage>.<pub-id pub-id-type="pmid">20110278</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jolma</surname><given-names>A.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Whitington</surname><given-names>T.</given-names></string-name>, <string-name><surname>Toivonen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Nitta</surname><given-names>K.R.</given-names></string-name>, <string-name><surname>Rastas</surname><given-names>P.</given-names></string-name>, <string-name><surname>Morgunova</surname><given-names>E.</given-names></string-name>, <string-name><surname>Enge</surname><given-names>M.</given-names></string-name>, <string-name><surname>Taipale</surname><given-names>M.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>DNA-binding specificities of human transcription factors</article-title>. <source>Cell</source>. <year>2013</year>; <volume>152</volume>:<fpage>327</fpage>–<lpage>339</lpage>.<pub-id pub-id-type="pmid">23332764</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fornes</surname><given-names>O.</given-names></string-name>, <string-name><surname>Castro-Mondragon</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Khan</surname><given-names>A.</given-names></string-name>, <string-name><surname>van der Lee</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Richmond</surname><given-names>P.A.</given-names></string-name>, <string-name><surname>Modi</surname><given-names>B.P.</given-names></string-name>, <string-name><surname>Correard</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gheorghe</surname><given-names>M.</given-names></string-name>, <string-name><surname>Baranasic</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>JASPAR 2020: update of the open-access database of transcription factor binding profiles</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D87</fpage>–<lpage>D92</lpage>.<pub-id pub-id-type="pmid">31701148</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berger</surname><given-names>M.F.</given-names></string-name>, <string-name><surname>Badis</surname><given-names>G.</given-names></string-name>, <string-name><surname>Gehrke</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Talukder</surname><given-names>S.</given-names></string-name>, <string-name><surname>Philippakis</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Pena-Castillo</surname><given-names>L.</given-names></string-name>, <string-name><surname>Alleyne</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Mnaimneh</surname><given-names>S.</given-names></string-name>, <string-name><surname>Botvinnik</surname><given-names>O.B.</given-names></string-name>, <string-name><surname>Chan</surname><given-names>E.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences</article-title>. <source>Cell</source>. <year>2008</year>; <volume>133</volume>:<fpage>1266</fpage>–<lpage>1276</lpage>.<pub-id pub-id-type="pmid">18585359</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hume</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Barrera</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>Gisselbrecht</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Bulyk</surname><given-names>M.L.</given-names></string-name></person-group><article-title>UniPROBE, update 2015: new tools and content for the online database of protein-binding microarray data on protein-DNA interactions</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>D117</fpage>–<lpage>D122</lpage>.<pub-id pub-id-type="pmid">25378322</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wei</surname><given-names>G.H.</given-names></string-name>, <string-name><surname>Badis</surname><given-names>G.</given-names></string-name>, <string-name><surname>Berger</surname><given-names>M.F.</given-names></string-name>, <string-name><surname>Kivioja</surname><given-names>T.</given-names></string-name>, <string-name><surname>Palin</surname><given-names>K.</given-names></string-name>, <string-name><surname>Enge</surname><given-names>M.</given-names></string-name>, <string-name><surname>Bonke</surname><given-names>M.</given-names></string-name>, <string-name><surname>Jolma</surname><given-names>A.</given-names></string-name>, <string-name><surname>Varjosalo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gehrke</surname><given-names>A.R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo</article-title>. <source>EMBO J.</source><year>2010</year>; <volume>29</volume>:<fpage>2147</fpage>–<lpage>2160</lpage>.<pub-id pub-id-type="pmid">20517297</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grant</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Bailey</surname><given-names>T.L.</given-names></string-name>, <string-name><surname>Noble</surname><given-names>W.S.</given-names></string-name></person-group><article-title>FIMO: scanning for occurrences of a given motif</article-title>. <source>Bioinformatics</source>. <year>2011</year>; <volume>27</volume>:<fpage>1017</fpage>–<lpage>1018</lpage>.<pub-id pub-id-type="pmid">21330290</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bailey</surname><given-names>T.L.</given-names></string-name>, <string-name><surname>Boden</surname><given-names>M.</given-names></string-name>, <string-name><surname>Buske</surname><given-names>F.A.</given-names></string-name>, <string-name><surname>Frith</surname><given-names>M.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Clementi</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>W.W.</given-names></string-name>, <string-name><surname>Noble</surname><given-names>W.S.</given-names></string-name></person-group><article-title>MEME SUITE: tools for motif discovery and searching</article-title>. <source>Nucleic Acids Res.</source><year>2009</year>; <volume>37</volume>:<fpage>W202</fpage>–<lpage>W208</lpage>.<pub-id pub-id-type="pmid">19458158</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Bai</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ai</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Han</surname><given-names>X.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ATACdb: a comprehensive human chromatin accessibility database</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D55</fpage>–<lpage>D64</lpage>.<pub-id pub-id-type="pmid">33125076</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Teng</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>X.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>OncoBase: a platform for decoding regulatory somatic mutations in human cancers</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D1044</fpage>–<lpage>D1055</lpage>.<pub-id pub-id-type="pmid">30445567</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Teng</surname><given-names>L.</given-names></string-name>, <string-name><surname>He</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>K.</given-names></string-name></person-group><article-title>4DGenome: a comprehensive database of chromatin interactions</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>:<fpage>2560</fpage>–<lpage>2564</lpage>.<pub-id pub-id-type="pmid">25788621</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tena</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Santos-Pereira</surname><given-names>J.M.</given-names></string-name></person-group><article-title>Topologically associating domains and regulatory landscapes in development, evolution and disease</article-title>. <source>Front. Cell Dev. Biol.</source><year>2021</year>; <volume>9</volume>:<fpage>702787</fpage>.<pub-id pub-id-type="pmid">34295901</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Galupa</surname><given-names>R.</given-names></string-name>, <string-name><surname>Heard</surname><given-names>E.</given-names></string-name></person-group><article-title>Topologically associating domains in chromosome architecture and gene regulatory landscapes during development, disease, and evolution</article-title>. <source>Cold Spring Harbor Symp. Quant. Biol.</source><year>2017</year>; <volume>82</volume>:<fpage>267</fpage>–<lpage>278</lpage>.<pub-id pub-id-type="pmid">29686034</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Song</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Kuang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>D.</given-names></string-name>, <string-name><surname>Choudhary</surname><given-names>M.N.K.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The 3D genome browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions</article-title>. <source>Genome Biol.</source><year>2018</year>; <volume>19</volume>:<fpage>151</fpage>.<pub-id pub-id-type="pmid">30286773</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sherry</surname><given-names>S.T.</given-names></string-name>, <string-name><surname>Ward</surname><given-names>M.H.</given-names></string-name>, <string-name><surname>Kholodov</surname><given-names>M.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>J.</given-names></string-name>, <string-name><surname>Phan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Smigielski</surname><given-names>E.M.</given-names></string-name>, <string-name><surname>Sirotkin</surname><given-names>K.</given-names></string-name></person-group><article-title>dbSNP: the NCBI database of genetic variation</article-title>. <source>Nucleic Acids Res.</source><year>2001</year>; <volume>29</volume>:<fpage>308</fpage>–<lpage>311</lpage>.<pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>T.</given-names></string-name>, <string-name><surname>Qian</surname><given-names>J.</given-names></string-name></person-group><article-title>EnhancerAtlas 2.0: an updated resource with enhancer annotation in 586 tissue/cell types across nine species</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D58</fpage>–<lpage>D64</lpage>.<pub-id pub-id-type="pmid">31740966</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Consortium, F., the, R.P., Clst, Forrest, A.R.</collab><string-name><surname>Kawaji</surname><given-names>H.</given-names></string-name>, <string-name><surname>Rehli</surname><given-names>M.</given-names></string-name>, <string-name><surname>Baillie</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>de Hoon</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Haberle</surname><given-names>V.</given-names></string-name>, <string-name><surname>Lassmann</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A promoter-level mammalian expression atlas</article-title>. <source>Nature</source>. <year>2014</year>; <volume>507</volume>:<fpage>462</fpage>–<lpage>470</lpage>.<pub-id pub-id-type="pmid">24670764</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dai</surname><given-names>X.</given-names></string-name>, <string-name><surname>Berry</surname><given-names>L.D.</given-names></string-name>, <string-name><surname>Cogan</surname><given-names>J.D.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Shyr</surname><given-names>Y.</given-names></string-name></person-group><article-title>HACER: an atlas of human active enhancers to interpret regulatory variants</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D106</fpage>–<lpage>D112</lpage>.<pub-id pub-id-type="pmid">30247654</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ashoor</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kleftogiannis</surname><given-names>D.</given-names></string-name>, <string-name><surname>Radovanovic</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bajic</surname><given-names>V.B.</given-names></string-name></person-group><article-title>DENdb: database of integrated human enhancers</article-title>. <source>Database (Oxford)</source>. <year>2015</year>; <volume>2015</volume>:<fpage>bav085</fpage>.<pub-id pub-id-type="pmid">26342387</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bai</surname><given-names>X.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ai</surname><given-names>B.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Han</surname><given-names>X.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Pan</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ENdb: a manually curated database of experimentally supported enhancers for human and mouse</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D51</fpage>–<lpage>D57</lpage>.<pub-id pub-id-type="pmid">31665430</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><collab>The Gene Ontology Consortium</collab><article-title>The gene ontology resource: 20 years and still GOing strong</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D330</fpage>–<lpage>D338</lpage>.<pub-id pub-id-type="pmid">30395331</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kanehisa</surname><given-names>M.</given-names></string-name>, <string-name><surname>Furumichi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Sato</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ishiguro-Watanabe</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tanabe</surname><given-names>M.</given-names></string-name></person-group><article-title>KEGG: integrating viruses and cellular organisms</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D545</fpage>–<lpage>D551</lpage>.<pub-id pub-id-type="pmid">33125081</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>G.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L.G.</given-names></string-name>, <string-name><surname>Han</surname><given-names>Y.</given-names></string-name>, <string-name><surname>He</surname><given-names>Q.Y.</given-names></string-name></person-group><article-title>clusterProfiler: an r package for comparing biological themes among gene clusters</article-title>. <source>OMICS</source>. <year>2012</year>; <volume>16</volume>:<fpage>284</fpage>–<lpage>287</lpage>.<pub-id pub-id-type="pmid">22455463</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Searcy</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Vincent</surname><given-names>E.B.</given-names></string-name>, <string-name><surname>Liberatore</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Yutzey</surname><given-names>K.E.</given-names></string-name></person-group><article-title>A GATA-dependent nkx-2.5 regulatory element activates early cardiac gene expression in transgenic mice</article-title>. <source>Development</source>. <year>1998</year>; <volume>125</volume>:<fpage>4461</fpage>–<lpage>4470</lpage>.<pub-id pub-id-type="pmid">9778505</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lien</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Mercer</surname><given-names>B.</given-names></string-name>, <string-name><surname>Webb</surname><given-names>R.</given-names></string-name>, <string-name><surname>Richardson</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Olson</surname><given-names>E.N.</given-names></string-name></person-group><article-title>Control of early cardiac-specific transcription of nkx2-5 by a GATA-dependent enhancer</article-title>. <source>Development</source>. <year>1999</year>; <volume>126</volume>:<fpage>75</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">9834187</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Akazawa</surname><given-names>H.</given-names></string-name>, <string-name><surname>Komuro</surname><given-names>I.</given-names></string-name></person-group><article-title>Cardiac transcription factor csx/nkx2-5: its role in cardiac development and diseases</article-title>. <source>Pharmacol. Ther.</source><year>2005</year>; <volume>107</volume>:<fpage>252</fpage>–<lpage>268</lpage>.<pub-id pub-id-type="pmid">15925411</pub-id></mixed-citation>
    </ref>
    <ref id="B60">
      <label>60.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tong</surname><given-names>Y.F.</given-names></string-name></person-group><article-title>Mutations of NKX2.5 and GATA4 genes in the development of congenital heart disease</article-title>. <source>Gene</source>. <year>2016</year>; <volume>588</volume>:<fpage>86</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">27154817</pub-id></mixed-citation>
    </ref>
    <ref id="B61">
      <label>61.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y.</given-names></string-name></person-group><article-title>Overexpression of S100A4 protein may be associated with the development and progression of pancreatic cancer</article-title>. <source>J. Cancer Res. Ther.</source><year>2018</year>; <volume>14</volume>:<fpage>S159</fpage>–<lpage>S166</lpage>.<pub-id pub-id-type="pmid">29578167</pub-id></mixed-citation>
    </ref>
    <ref id="B62">
      <label>62.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Che</surname><given-names>P.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Han</surname><given-names>X.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Sellers</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Londono-Joshi</surname><given-names>A.I.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>G.Q.</given-names></string-name>, <string-name><surname>Buchsbaum</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Christein</surname><given-names>J.D.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>Q.</given-names></string-name><etal>et al</etal>.</person-group><article-title>S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by src and focal adhesion kinase</article-title>. <source>Sci. Rep.</source><year>2015</year>; <volume>5</volume>:<fpage>8453</fpage>.<pub-id pub-id-type="pmid">25677816</pub-id></mixed-citation>
    </ref>
    <ref id="B63">
      <label>63.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sekine</surname><given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>N.</given-names></string-name>, <string-name><surname>Sato</surname><given-names>K.</given-names></string-name>, <string-name><surname>Saiki</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yoshino</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umetsu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Jin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Nagase</surname><given-names>H.</given-names></string-name>, <string-name><surname>Gu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Fukushige</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells</article-title>. <source>Biochem. Biophys. Res. Commun.</source><year>2012</year>; <volume>429</volume>:<fpage>214</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">23085231</pub-id></mixed-citation>
    </ref>
    <ref id="B64">
      <label>64.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ohuchida</surname><given-names>K.</given-names></string-name>, <string-name><surname>Mizumoto</surname><given-names>K.</given-names></string-name>, <string-name><surname>Ishikawa</surname><given-names>N.</given-names></string-name>, <string-name><surname>Fujii</surname><given-names>K.</given-names></string-name>, <string-name><surname>Konomi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Nagai</surname><given-names>E.</given-names></string-name>, <string-name><surname>Yamaguchi</surname><given-names>K.</given-names></string-name>, <string-name><surname>Tsuneyoshi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tanaka</surname><given-names>M.</given-names></string-name></person-group><article-title>The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target</article-title>. <source>Clin. Cancer Res.</source><year>2005</year>; <volume>11</volume>:<fpage>7785</fpage>–<lpage>7793</lpage>.<pub-id pub-id-type="pmid">16278400</pub-id></mixed-citation>
    </ref>
    <ref id="B65">
      <label>65.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>J.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Song</surname><given-names>L.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ou</surname><given-names>D.</given-names></string-name>, <string-name><surname>He</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Ouyang</surname><given-names>X.</given-names></string-name></person-group><article-title>Impact of S100A4 expression on clinicopathological characteristics and prognosis in pancreatic cancer: a meta-analysis</article-title>. <source>Dis. Markers</source>. <year>2016</year>; <volume>2016</volume>:<fpage>8137378</fpage>.<pub-id pub-id-type="pmid">26903691</pub-id></mixed-citation>
    </ref>
    <ref id="B66">
      <label>66.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kozono</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ohuchida</surname><given-names>K.</given-names></string-name>, <string-name><surname>Ohtsuka</surname><given-names>T.</given-names></string-name>, <string-name><surname>Cui</surname><given-names>L.</given-names></string-name>, <string-name><surname>Eguchi</surname><given-names>D.</given-names></string-name>, <string-name><surname>Fujiwara</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mizumoto</surname><given-names>K.</given-names></string-name>, <string-name><surname>Tanaka</surname><given-names>M.</given-names></string-name></person-group><article-title>S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells</article-title>. <source>Oncol. Rep.</source><year>2013</year>; <volume>30</volume>:<fpage>1601</fpage>–<lpage>1608</lpage>.<pub-id pub-id-type="pmid">23900547</pub-id></mixed-citation>
    </ref>
    <ref id="B67">
      <label>67.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ai</surname><given-names>KX.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>LY.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>XY.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>W.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>HZ.</given-names></string-name></person-group><article-title>Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer</article-title>. <source>World J. Gastroenterol.</source><year>2008</year>; <volume>14</volume>:<fpage>1931</fpage>–<lpage>1935</lpage>.<pub-id pub-id-type="pmid">18350635</pub-id></mixed-citation>
    </ref>
    <ref id="B68">
      <label>68.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhuang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Dong</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Hou</surname><given-names>B.</given-names></string-name></person-group><article-title>Prognostic values and immune suppression of the S100A family in pancreatic cancer</article-title>. <source>J. Cell Mol. Med.</source><year>2021</year>; <volume>25</volume>:<fpage>3006</fpage>–<lpage>3018</lpage>.<pub-id pub-id-type="pmid">33580614</pub-id></mixed-citation>
    </ref>
    <ref id="B69">
      <label>69.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takahashi</surname><given-names>K.</given-names></string-name>, <string-name><surname>Ehata</surname><given-names>S.</given-names></string-name>, <string-name><surname>Miyauchi</surname><given-names>K.</given-names></string-name>, <string-name><surname>Morishita</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Miyazawa</surname><given-names>K.</given-names></string-name>, <string-name><surname>Miyazono</surname><given-names>K.</given-names></string-name></person-group><article-title>Neurotensin receptor 1 signaling promotes pancreatic cancer progression</article-title>. <source>Mol Oncol</source>. <year>2021</year>; <volume>15</volume>:<fpage>151</fpage>–<lpage>166</lpage>.<pub-id pub-id-type="pmid">33034134</pub-id></mixed-citation>
    </ref>
    <ref id="B70">
      <label>70.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Long</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>W.B.</given-names></string-name>, <string-name><surname>Wangpaichitr</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tsukamoto</surname><given-names>T.</given-names></string-name>, <string-name><surname>Savaraj</surname><given-names>N.</given-names></string-name>, <string-name><surname>Feun</surname><given-names>L.G.</given-names></string-name>, <string-name><surname>Kuo</surname><given-names>M.T.</given-names></string-name></person-group><article-title>Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction</article-title>. <source>Mol. Cancer Ther.</source><year>2013</year>; <volume>12</volume>:<fpage>2581</fpage>–<lpage>2590</lpage>.<pub-id pub-id-type="pmid">23979920</pub-id></mixed-citation>
    </ref>
    <ref id="B71">
      <label>71.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mehra</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>N.</given-names></string-name>, <string-name><surname>Nagathihalli</surname><given-names>N.</given-names></string-name></person-group><article-title>Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress</article-title>. <source>Cancers (Basel)</source>. <year>2021</year>; <volume>13</volume>:<fpage>4434</fpage>.<pub-id pub-id-type="pmid">34503244</pub-id></mixed-citation>
    </ref>
    <ref id="B72">
      <label>72.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>N.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>D.Y.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>J.T.</given-names></string-name>, <string-name><surname>Ge</surname><given-names>N.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>S.Y.</given-names></string-name></person-group><article-title>Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway</article-title>. <source>World. J. Gastrointest. Oncol.</source><year>2021</year>; <volume>13</volume>:<fpage>1164</fpage>–<lpage>1183</lpage>.<pub-id pub-id-type="pmid">34616521</pub-id></mixed-citation>
    </ref>
    <ref id="B73">
      <label>73.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>MacDonald</surname><given-names>R.J.</given-names></string-name></person-group><article-title>Signaling and transcriptional control of pancreatic organogenesis</article-title>. <source>Curr. Opin. Genet. Dev.</source><year>2002</year>; <volume>12</volume>:<fpage>540</fpage>–<lpage>547</lpage>.<pub-id pub-id-type="pmid">12200159</pub-id></mixed-citation>
    </ref>
    <ref id="B74">
      <label>74.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Vas</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Kopp</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Heliot</surname><given-names>C.</given-names></string-name>, <string-name><surname>Sander</surname><given-names>M.</given-names></string-name>, <string-name><surname>Cereghini</surname><given-names>S.</given-names></string-name>, <string-name><surname>Haumaitre</surname><given-names>C.</given-names></string-name></person-group><article-title>Hnf1b controls pancreas morphogenesis and the generation of ngn3+ endocrine progenitors</article-title>. <source>Development</source>. <year>2015</year>; <volume>142</volume>:<fpage>871</fpage>–<lpage>882</lpage>.<pub-id pub-id-type="pmid">25715395</pub-id></mixed-citation>
    </ref>
    <ref id="B75">
      <label>75.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Edghill</surname><given-names>E.L.</given-names></string-name>, <string-name><surname>Bingham</surname><given-names>C.</given-names></string-name>, <string-name><surname>Slingerland</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Minton</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Noordam</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ellard</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hattersley</surname><given-names>A.T.</given-names></string-name></person-group><article-title>Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development</article-title>. <source>Diabet. Med.</source><year>2006</year>; <volume>23</volume>:<fpage>1301</fpage>–<lpage>1306</lpage>.<pub-id pub-id-type="pmid">17116179</pub-id></mixed-citation>
    </ref>
    <ref id="B76">
      <label>76.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cui</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Su</surname><given-names>M.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Han</surname><given-names>X.</given-names></string-name>, <string-name><surname>He</surname><given-names>H.</given-names></string-name></person-group><article-title>EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2</article-title>. <source>Cell Death. Dis.</source><year>2021</year>; <volume>12</volume>:<fpage>264</fpage>.<pub-id pub-id-type="pmid">33712565</pub-id></mixed-citation>
    </ref>
    <ref id="B77">
      <label>77.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McLean</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Bristor</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hiller</surname><given-names>M.</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>S.L.</given-names></string-name>, <string-name><surname>Schaar</surname><given-names>B.T.</given-names></string-name>, <string-name><surname>Lowe</surname><given-names>C.B.</given-names></string-name>, <string-name><surname>Wenger</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Bejerano</surname><given-names>G.</given-names></string-name></person-group><article-title>GREAT improves functional interpretation of cis-regulatory regions</article-title>. <source>Nat. Biotechnol.</source><year>2010</year>; <volume>28</volume>:<fpage>495</fpage>–<lpage>501</lpage>.<pub-id pub-id-type="pmid">20436461</pub-id></mixed-citation>
    </ref>
    <ref id="B78">
      <label>78.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bartosovic</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kabbe</surname><given-names>M.</given-names></string-name>, <string-name><surname>Castelo-Branco</surname><given-names>G.</given-names></string-name></person-group><article-title>Single-cell CUT&amp;Tag profiles histone modifications and transcription factors in complex tissues</article-title>. <source>Nat. Biotechnol.</source><year>2021</year>; <volume>39</volume>:<fpage>825</fpage>–<lpage>835</lpage>.<pub-id pub-id-type="pmid">33846645</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
